Recent methods for assessing osteoporosis and fracture risk

Recent Patents on Endocrine, Metabolic and Immune Drug Discovery

Volumn 8, Issue 1, 2014, Pages 48-59

  Imai, Kazuhiro ^a  

^a UNIVERSITY OF TOKYO   (Japan)

Author keywords

Bone metabolic marker; Bone mineral density; Finite element method; Fracture risk; Hip structure analysis; Osteoporosis assessment

Indexed keywords

BIOLOGICAL MARKER;

BONE DENSITY; BONE MATRIX; BONE STRENGTH; CLINICAL ASSESSMENT TOOL; COMPUTER ASSISTED TOMOGRAPHY; DUAL ENERGY X RAY ABSORPTIOMETRY; ECHOGRAPHY; FINITE ELEMENT ANALYSIS; FRACTURE; FRACTURE RISK ASSESSMENT TOOL; HIP STRUCTURE ANALYSIS; HUMAN; ORTHOPEDIC SOFTWARE; OSSIFICATION; OSTEOLYSIS; OSTEOPOROSIS; PHARMACEUTICAL CARE; PRIORITY JOURNAL; QUANTITATIVE ULTRASOUND; REVIEW; RISK ASSESSMENT; COMPUTER ASSISTED DIAGNOSIS; METABOLISM; OSTEOPOROTIC FRACTURES; PATENT; PROCEDURES;

BIOLOGICAL MARKERS; BONE DENSITY; DIAGNOSIS, COMPUTER-ASSISTED; FINITE ELEMENT ANALYSIS; HUMANS; OSTEOPOROSIS; OSTEOPOROTIC FRACTURES; PATENTS AS TOPIC; RISK ASSESSMENT; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84895445002     PISSN: 18722148     EISSN: None     Source Type: Journal    
DOI: 10.2174/1872214808666140118223801     Document Type: Review

References (152)

1. World Health Organization. Assessment of fracture risk and its application to screening for postmenopausal osteoporosis. Report of a WHO Study Group. World Health Organ Tech Rep Ser 1994; 843: 1-129.
2. Cummings SR, Kelsey JL, Nevitt MC, O'Dowd KJ. Epidemiology of osteoporosis and osteoporotic fractures. Epidemiol Rev 1985; 7: 178-208.
3. Eastell R, Reid DM, Compston J, Cooper C, Fogelman I, Francis RM, et al. Secondary prevention of osteoporosis: When should a non-vertebral fracture be a trigger for action? Q J Med 2001; 94: 575-97.
4. Wolinsky FD, Fitzgerald JF, Stump TE. The effect of hip fracture on mortality, hospitalization, and functional status: A prospective study. Am J Public Health 1997; 87: 398-403.
5. rd. Epidemiology of spinal osteoporosis. Spine 1997; 22(suppl): S2-11.
6. Svedbom A, Hernlund E, Ivergard M, Compston J, Cooper C, Stenmark J, et al. Osteoporosis in the European Union: A compendium of country-specific reports. Arch Osteoporos 2013; 8: 137.
7. Imai K. Alendronate sodium hydrate (oral jelly) for the treatment of osteoporosis: Review of a novel, easy to swallow formulation. Clin Interv Aging 2013; 8: 681-8.
8. Vasikaran SD, Khan S, McCloskey EV, Kanis JA. Sustained response to intravenous alendronate in postmenopausal osteoporosis. Bone 1995; 17: 517-20.
9. NIH consensus development panel on osteoporosis prevention, diagnosis, and therapy. Osteoporosis prevention, diagnosis, and therapy. JAMA 2001; 285: 785-95.
10. Kanis JA, Delmas P, Burckhardt P, Cooper C, Torgerson D. Guidelines for diagnosis and management of osteoporosis. The European Foundation for Osteoporosis and Bone Disease. Osteoporos Int 1997; 7: 390-406.
11. Imai K. Recent methods for assessing bone mineral density, bone strength, fracture risk and therapeutic effects on osteoporosis. Recent Pat Endocr Metab Immune Drug Discov 2010; 4: 34-42.
12. Kanis JA, Johnell O, Oden A, Johansson H, McCloskey E. FRAX™and the assessment of fracture probability in men and women from the UK. Osteoporos Int 2008; 19: 385-97.
13. Kanis JA, Oden A, Johansson H, Borgström F, Ström O, McCloskey E. FRAX® and its applications to clinical practice. Bone 2009; 44: 734-43.
14. Kanis JA, McCloskey EV, Johansson H, Odén A, Borgström F, Strom O. Development and use of FRAX® in osteoporosis. Osteoporosis Int 2010; 21(Suppl): S407-13.
15. Imai K, Ohnishi I, Matsumoto T, Yamamoto S, Nakamura K. Assessment of vertebral fracture risk and therapeutic effects of alendronate in postmenopausal women using a quantitative computed tomography-based nonlinear finite element method. Osteoporos Int 2009; 20: 801-10.
16. Imai K. Vertebral fracture risk and alendronate effects on osteoporosis assessed by a computed tomography-based nonlinear finite element method. J Bone Miner Metab 2011; 29: 645-51.
17. Dissing, E. Method of and an apparatus for examining a sample or a material by measuring the absorption of--or X-ray radiation. US3944830 (1976).
18. Fletcher, J.C., Cameron, J.R., Judy, P.F. Method and system for in vivo measurement of bone tissue using a two level energy source. US3996471 (1976).
19. Deluca, H.F., Biship, C.W., Mazess, R.B., Gallagher, J.C. Method for treating and preventing loss of bone mass. US5104864 (1992).
20. Stein, J.A. Bone densitometer. US5148455 (1992).
21. Takanori, M. Bone densitometer. JP2013153999 (2013).
22. Karellas, A. Dual-energy system for quantitative radiographic imaging. US5150394 (1992).
23. Uebelhart D, Duboeuf F, Meunier PJ, Delmas PD. Lateral dualphoton absorptiometry: A new technique to measure the bone mineral density at the lumbar spine. J Bone Miner Res 1990; 5: 525-31.
24. Rüegsegger P, Elsasser U, Anliker M, Gnehm H, Kind H, Prader A. Quantification of bone mineralization using computed tomography. Radiology 1976; 121: 93-9.
25. Isherwood I, Rutherford RA, Pullan BR, Adams PH. Bone-mineral estimation by computer-assisted transverse axial tomography. Lancet 1976; 2: 712-5.
26. Genant HK, Boyd D, Rosenfeld D, Abols Y, Cann CE. Computed tomography. Non-invasive measurements of bone mass and their clinical application. Florida, CRC Press: 1981; 121-49.
27. Powell MR, Kolb FO, Genant HK, Cann CE, Stebler BG. Comparison of dual photon absorbtiometry and quantitative computer tomography of the lumbar spine in the same subjects. Clinical disorders of bone and mineral metabolism. Amsterdam: Excerpta Medica 1983; 58-60.
28. rd. Prediction of vertebral body compressive fracture using quantitative computed tomography. J Bone Joint Surg 1985; 67-A: 1206-14.
29. Cann CE, Genant HK, Kolb FO, Ettinger B. Quantitative computed tomography for prediction of vertebral fracture risk. Bone 1985; 6: 1-7.
30. Mosekilde L, Bentzen SM, Ortoft G, Jorgensen J. The predictive value of quantitative computed tomography for vertebral body compressive strength and ash density. Bone 1989; 10: 465-70.
31. Eriksson SA, Isberg BO, Lindgren JU. Prediction of vertebral strength by dual photon absorptiometry and quantitative computed tomography. Calcif Tissue Int 1989; 44: 243-50.
32. Edmondston SJ, Singer KP, Day RE, Breidahl PD, Price RI. In vitro relationships between vertebral body density, size and compressive strength in the elderly thoracolumbar spine. Clin Biomecha 1994; 9: 180-6.
33. Cheng XG, Nicholson PH, Boonen S, Lowet G, Brys P, Aerssens J, et al. Prediction of vertebral strength in vitro by spinal bone densitometry and calcaneal ultrasound. J Bone Miner Res 1997; 12: 1721-8.
34. Myers BS, Arbogast KB, Lobaugh B, Harper KD, Richardson WJ, Drezner MK. Improved assessment of lumbar vertebral body strength using supine lateral dual-energy X-ray absorptiometry. J Bone Miner Res 1994; 9: 687-93.
35. Bjarnason K, Hassager C, Svendsen OL, Stang H, Christiansen C. Anteroposterior and lateral spinal DXA for the assessment of vertebral body strength: Comparison with hip and forearm measurement. Osteoporosis Int 1996; 6: 37-42.
36. Kalender WA, Klotz E, Suess C. Vertebral bone mineral analysis: An integrated approach with CT. Radiology 1987; 164: 419-23.
37. Huda W, Morin RL. Patient doses in bone mineral densitometry. Br J Radiol 1996; 69: 422-5.
38. Beck TJ, Ruff CB, Warden KE, Scott WW Jr, Rao GU. Predicting femoral neck strength from bone mineral data. A structural approach. Invest Radiol 1990; 25: 6-18.
39. Charles, Jr. H.K., Beck, T.J., Feldmesser, H.S., Magee, T.C. Techniques for deriving tissue structure from multiple projection dualenergy X-ray absorptiometry. US6816564 (2004).
40. Forwood MR, Bailey DA, Beck TJ, Mirwald RL, Baxter-Jones AD, Uusi-Rasi K. Sexual dimorphism of the femoral neck during the adolescent growth spurt: A structural analysis. Bone 2004; 35: 973-81.
41. Janz KF, Gilmore JM, Levy SM, Letuchy EM, Burns TL, Beck TJ. Physical activity and femoral neck bone strength during childhood: The iowa bone development study. Bone 2007; 41: 216-22.
42. McKay HA, MacLean L, Petit M, MacKelvie-O'Brien K, Janssen P, Beck T, et al. "Bounce at the Bell": A novel program of short bouts of exercise improves proximal femur bone mass in early pubertal children. Br J Sports Med 2005; 39: 521-6.
43. Beck TJ, Looker AC, Ruff CB, Sievanen H, Wahner HW. Structural trends in the aging femoral neck and proximal shaft: Analysis of the Third National Health and Nutrition Examination Survey dual-energy X-ray absorptiometry data. J Bone Miner Res 2000; 15: 2297-304.
44. Crabtree N, Lunt M, Holt G, Kröger H, Burger H, Grazio S, et al. Hip geometry, bone mineral distribution, and bone strength in European men and women: The EPOS study. Bone 2000; 27: 151-9.
45. Khoo BC, Beck TJ, Qiao QH, Parakh P, Semanick L, Prince RL, et al. In vivo short-term precision of hip structure analysis variables in comparison with bone mineral density using paired dual-energy X-ray absorptiometry scans from multi-center clinical trials. Bone 2005; 37: 112-21.
46. Yates LB, Karasik D, Beck TJ, Cupples LA, Kiel DP. Hip structural geometry in old and old-old age: Similarities and differences between men and women. Bone 2007; 41:722-32.
47. Beck TJ. Extending DXA beyond bone mineral density: Understanding hip structure analysis. Curr Osteoporos Rep 2007; 5: 49-55.
48. Faulkner KG, Wacker WK, Barden HS, Simonelli C, Burke PK, Ragi S, et al. Femur strength index predicts hip fracture independent of bone density and hip axis length. Osteoporos Int 2006; 17:593-9.
49. Leslie WD, Pahlavan PS, Tsang JF, Lix LM. Prediction of hip and other osteoporotic fractures from hip geometry in a large clinical cohort. Osteoporos Int 2009; 20: 1767-74.
50. Ahlborg HG, Nguyen ND, Nguyen TV, Center JR, Eisman JA. Contribution of hip strength indices to hip fracture risk in elderly men and women. J Bone Miner Res 2005; 20: 1820-7.
51. Rivadeneira F, Zillikens MC, De Laet CE, Hofman A, Uitterlinden AG, Beck TJ, et al. Femoral neck BMD is a strong predictor of hip fracture susceptibility in elderly men and women because it detects cortical bone instability: the Rotterdam Study. J Bone Miner Res 2007; 22: 1781-90.
52. Kaptoge S, Beck TJ, Reeve J, Stone KL, Hillier TA, Cauley JA, et al. Prediction of incident hip fracture risk by femur geometry variables measured by hip structural analysis in the study of osteoporotic fractures. J Bone Miner Res 2008; 23: 1892-904.
53. Brekelmans WA, Poort HW, Slooff TJ. A new method to analyse the mechanical behaviour of skeletal parts. Acta Orthop Scand 1972; 43: 301-17.
54. Huiskes R, Chao EY. A survey of finite element analysis in orthopedic biomechanics: The first decade. J Biomech 1983; 16: 385-409.
55. Cann, C.E., Faulkner, K.G. Method for improved prediction of bone fracture risk using bone mineral density in structural analysis. US5172695 (1992).
56. Cody DD, Gross GJ, Hou FJ, Spencer HJ, Goldstein SA, Fyhrie DP. Femoral strength is better predicted by finite element models than QCT and DXA. J Biomech 1999; 32: 1013-20.
57. Keyak JH, Rossi SA, Jones KA, Skinner HB. Prediction of femoral fracture load using automated finite element modeling. J Biomech 1998; 31: 125-33.
58. Keyak JH, Rossi SA, Jones KA, Les CM, Skinner HB. Prediction of fracture location in the proximal femur using finite element models. Med Eng Phys 2001; 23: 657-64.
59. Keyak JH. Improved prediction of proximal femoral fracture load using nonlinear finite element models. Med Eng Phys 2001; 23: 165-73.
60. Bessho M, Ohnishi I, Matsuyama J, Matsumoto T, Imai K, Nakamura K. Prediction of strength and strain of the proximal femur by a CT-based finite element method. J Biomech 2007; 40: 1745-53.
61. Danielson ME, Beck TJ, Karlamangla AS, Greendale GA, Atkinson EJ, Lian Y, et al. A comparison of DXA and CT based methods for estimating the strength of the femoral neck in postmenopausal women. Osteoporos Int 2013; 24: 1379-88.
62. Faulkner KG, Cann CE, Hasegawa BH. Effect of bone distribution on vertebral strength: Assessment with patient-specific nonlinear finite element analysis. Radiology 1991; 179: 669-74.
63. Silva MJ, Keaveny TM, Hayes WC. Computed tomography-based finite element analysis predicts failure loads and fracture patterns for vertebral sections. J Orthop Res 1998; 16: 300-8.
64. Martin H, Werner J, Andresen R, Schober HC, Schmitz KP. Noninvasive assessment of stiffness and failure load of human vertebrae from CT-data. Biomed Tech 1998; 43: 82-8.
65. Buckley JM, Loo K, Motherway J. Comparison of quantitative computed tomography-based measures in predicting vertebral strength. Bone 2007; 40: 767-74.
66. Crawford RP, Cann CE, Keaveny TM. Finite element models predict in vitro vertebral body compressive strength better than quantitative computed tomography. Bone 2003; 33: 744-50.
67. Liebschner MA, Kopperdahl DL, Rosenberg WS, Keaveny TM. Finite element modeling of the human thoracolumbar spine. Spine 2003; 28: 559-65.
68. Imai K, Ohnishi I, Bessho M, Nakamura K. Nonlinear finite element model predicts vertebral bone strength and fracture site. Spine 2006; 31: 1789-94.
69. Lian KC, Lang TF, Keyak JH, Modin GW, Rehman Q, Do L, et al. Differences in hip quantitative computed tomography (QCT) measurements of bone mineral density and bone strength between glucocorticoid-treated and glucocorticoid-naive postmenopausal women. Osteoporos Int 2005; 16: 642-50.
70. Keaveny TM, Donley DW, Hoffmann PF, Mitlak BH, Glass EV, San Martin JA. Effects of teriparatide and alendronate on vertebral strength as assessed by finite element modeling of QCT scans in women with osteoporosis. J Bone Miner Res 2007; 22: 149-57.
71. Yang L, Peel N, Clowes JA, McCloskey EV, Eastell R. Use of DXA-based structural engineering models of the proximal femur to discriminate hip fracture. J Bone Miner Res 2009; 24: 33-42.
72. Hans D, Arlot ME, Schott AM, Roux JP, Kotzki PO, Meunier PJ. Do ultrasound measurements on the os calcis reflect more the bone microarchitecture than the bone mass? A two-dimensional histomorphometric study. Bone 1995; 16: 295-300.
73. Njeh CF, Hans D, Fuerst T, Gluer CC, Genant HK, Eds. Quantitative ultrasound: Assessment of osteoporisis and bone status-Calcaneal quantitative ultrasound. London, Martin Dunitz 1999; 109-44.
74. Njeh CF, Hans D, Fuerst T, Gluer CC, Genant HK., Eds. Quantitative ultrasound: Assessment of osteoporisis and bone status-Nonheel quantitative ultrasound devices. London, Martin Dunitz 1999; 145-62.
75. Durosier C, Hans D, Krieg MA, Schott AM. Prediction and discrimination of osteoporotic hip fracture in postmenopausal women. J Clin Densitom 2006; 9: 475-95.
76. Krieg MA, Barkmann R, Gonnelli S, Stewart A, Bauer DC, Del Rio Barquero L, et al. Quantitative ultrasound in the management of osteoporosis: The 2007 ISCD official positions. J Clin Densitom Assess Skelet Health 2008; 11: 163-87.
77. Porter RW, Miller CG, Grainger D, Palmer SB. Prediction of hip fracture in elderly women: A prospective study. BMJ 1990; 301: 638-41.
78. rd, Lappe J, Recker RR, Brandenburger GH. Ultrasound velocity, through bone predicts incident vertebral deformity. J Bone Miner Res 1995; 10: 341-5.
79. Hans D, Dargent-Molina P, Schott AM, Sebert JL, Cormier C, Kotzki PO, et al. Ultrasonographic heel measurements to predict hip fracture in elderly women: The EPIDOS prospective study. Lancet 1996; 348: 511-4.
80. Bauer DC, Glüer CC, Cauley JA, Vogt TM, Ensrud KE, Genant HK, et al. Broadband ultrasound attenuation predicts fractures strongly and independently of densitometry in older women. A prospective study. Study of Osteoporotic Fractures Research Group. Arch Intern Med 1997; 157:629-634.
81. Pluijm SM, Graafmans WC, Bouter LM, Lips P. Ultrasound measurements for the prediction of osteoporotic fractures in elderly people. Osteoporos Int 1999; 9: 550-6.
82. Fujiwara S, Sone T, Yamazaki K, Yoshimura N, Nakatsuka K, Masunari N, et al. Heel bone ultrasound predicts non-spine fracture in Japanese men and women. Osteoporos Int 2005; 16: 2107-12.
83. Schott AM, Hans D, Duboeuf F, Dargent-Molina P, Hajri T, Bréart G, et al. Quantitative ultrasound parameters as well as bone mineral density are better predictors of trochanteric than cervical hip fractures in elderly women. Results from the EPIDOS study. Bone 2005; 37: 858-63.
84. Glüer MG, Minne HW, Glüer CC, Lazarescu AD, Pfeifer M, Perschel FH, et al. Prospective identification of postmenopausal osteoporotic women at high vertebral fracture risk by radiography, bone densitometry, quantitative ultrasound, and laboratory findings: Results from the PIOS study. J Clin Densitom 2005; 8: 386-95.
85. Krieg MA, Cornuz J, Ruffieux C, Van Melle G, Büche D, Dambacher MA, et al. Prediction of hip fracture risk by quantitative ultrasound in more than 7000 Swiss women > or = 70 years of age: Comparison of three technologically different bone ultrasound devices in the SEMOF study. J Bone Miner Res 2006; 21: 1457-63.
86. Díez-Pérez A, González-Macías J, Marín F, Abizanda M, Alvarez R, Gimeno A, et al. Prediction of absolute risk of non-spinal fractures using clinical risk factors and heel quantitative ultrasound. Osteoporos Int 2007; 18: 629-39.
87. Bauer DC, Ewing S, Cauley J, Ensrud K, Cummings S, Orwoll E. Quantitative ultrasound predicts hip and non-spine fracture in men: The MrOS study. Osteoporos Int 2007; 18: 771-77.
88. Durosier C, Hans D, Krieg MA, Schott AM. Prediction and discrimination of osteoporotic hip fracture in postmenopausal women. J Clin Densitom 2006; 9: 475-95.
89. Frost ML, Blake GM, Fogelman I. Can the WHO criteria for diagnosing osteoporosis be applied to calcaneal quantitative ultrasound? Osteoporosis Int 2000; 11: 321-30.
90. Faulkner KG, von Stetten E, Miller P. Discordance in patient classification using T-scores. J Clin Densitom 1999; 2: 343-50.
91. Damilakis J, Perisinakis K, Gourtsoyiannis N. Imaging ultrasonometry of the calcaneus: Optimum T-score thresholds for the identification of osteoporotic subjects. Calcif Tissue Int 2001; 68: 219-24.
92. Knapp KM, Blake GM, Spector TD, Fogelman I. Can the WHO definition of osteoporosis be applied to multisite axial transmission quantitative ultrasound? Osteoporosis Int 2004; 15: 367-74.
93. Clowes JA, Peel NF, Eastell R. Device-specific thresholds to diagnose osteoporosis at the proximal femur: An approach to interpret ing peripheral bone measurements in clinical practice. Osteoporosis Int 2006; 17: 1293-302.
94. Siffert RS, Kaufman JJ. Ultrasonic bone assessment: The time has come. Bone 2007; 40: 5-8.
95. Roux C, Fournier B, Laugier P, Chappard C, Kolta S, Dougados M, et al. Broadband ultrasound attenuation imaging: A new imaging method in osteoporosis. J Bone Miner Res 1996; 11: 1112-8.
96. Hans D, Arlot ME, Schott AM, Roux JP, Kotzki PO, Meunier PJ. Do ultrasound measurements on the os calcis reflect more the bone microarchitecture than the bone mass?: A two-dimensional histomorphometric study. Bone 1995; 16: 295-300.
97. Seeman E, Delmas PD. Bone quality-the material and structural basis of bone strength and fragility. N Engl J Med 2006; 354: 2250-61.
98. Ammann P, Rizzoli R. Bone strength and its determinants. Osteoporosis Int 2003; 14: S13-8.
99. Hans D, Wu C, Njeh CF, Zhao S, Augat P, Newitt D, et al. Ultrasound velocity of trabecular cubes reflects mainly bone density and elasticity. Calcif Tissue Int 1999; 64: 18-23.
100. Gluer CC. Quantitative ultrasound-it is time to focus research efforts. Bone 2007; 40: 9-13.
101. Gluer CC, Wu CY, Genant HK. Broadband ultrasound attenuation signals depend on trabecular orientation: An in vitro study. Osteoporosis Int 1993; 3: 185-91.
102. Gluer CC, Wu CY, Jergas M, Goldstein SA, Genant HK. Three quantitative ultrasound parameters reflect bone structure. Calcif Tissue Int 1994; 55: 46-52.
103. Bouxsein ML, Coan BS, Lee SC. Prediction of the strength of the elderly proximal femur by bone mineral density and quantitative ultrasound measurements of the heel and tibia. Bone 1999; 25: 49-54.
104. Bouxsein ML, Radloff SE. Quantitative ultrasound of the calcaneus reflects the mechanical properties of calcaneal trabecular bone. J Bone Miner Res 1997; 12: 839-46.
105. Lochmüller EM, Bürklein D, Kuhn V, Glaser C, Müller R, Glüer CC, et al. Mechanical strength of the thoracolumbar spine in the elderly: Prediction from in situ dual-energy X-ray absorptiometry, quantitative computed tomography, upper and lower limb peripheral quantitative computed tomography, and quantitative ultrasound. Bone 2002; 31: 77-84.
106. Hakulinen MA, Toyras J, Saarakkala S, Hirvonen J, Kroger H, Jurvelin JS. Ability of ultrasound backscattering to predict mechanical properties of bovine trabecular bone. Ultrasound Med Biol 2004; 30: 919-27.
107. Han S, Medige J, Faran K, Feng Z, Ziv I. The ability of quantitative ultrasound to predict the mechanical properties of trabecular bone under different strain rates. Med Eng Phys 1997; 19: 742-7.
108. Njeh CF, Kuo CW, Langton CM, Atrah HI, Boivin CM. Prediction of human femoral bone strength using ultrasound velocity and BMD. An in vitro study. Osteoporosis Int 1997; 7: 471-7.
109. Durosier C, Hans D, Krieg MA, Ruffieux C, Cornuz J, Meunier PJ, et al. Combining clinical factors and quantitative ultrasound improves the detection of women both at low and high risk for hip fracture. Osteoporosis Int 2007; 18: 1651-9.
110. Guglielmi G, Rossini M, Nicolosi MG, Ragno A, Lentini G, de Terlizzi F. Three-year prospective study on fracture risk in postmenopausal women by quantitative ultrasound at the phalanges. J Clin Densitom 2013; 16: 341-6.
111. National Osteoporosis Foundation. Clinician's guide to prevention and treatment of osteoporosis. National Osteoporosis Foundation: Washington 2008.
112. Watts NB, Lewiecki EM, Miller PD, Baim S. National osteoporosis foundation 2008 clinician's guide to prevention and treatment of osteoporosis and the world health organization fracture risk assessment tool (FRAX): What they mean to the bone densitometrist and bone technologist. J Clin Densitom 2008; 11: 473-7.
113. Hans DB, Kanis JA, Baim S, Bilezikian JP, Binkley N, Cauley JA, et al. Joint official positions of the international society for clinical densitometry and international osteoporosis foundation on FRAX®. Executive summary of the 2010 Position development conference on interpretation and use of FRAX® in clinical practice. J Clin Densitom 2011; 14: 171-80.
114. Dargent-Molina P, Favier F, Grandjean H, Baudoin C, Schott AM, Hausherr E, et al. Fall-related factors and risk of hip fracture: The EPIDOS prospective study. Lancet 1996; 348: 145-9.
115. Saag KG, Geusens P. Progress in osteoporosis and fracture prevention: focus on postmenopausal women. Arthritis Res Ther 2009; 11(5): 251.
116. Kanis JA, Oden A, Johnell O, Johansson H, De Laet C, Brown J, et al. The use of clinical risk factors enhances the performance of BMD in the prediction of hip and osteoporotic fractures in men and women. Osteoporos Int 2007; 18: 1033-46.
117. van Helden S, Cals J, Kessels F, Brink P, Dinant GJ, Geusens P. Risk of new clinical fractures within 2 years following a fracture. Osteoporos Int 2006; 17: 348-54.
118. Center JR, Bliuc D, Nguyen TV, Eisman JA. Risk of subsequent fracture after low-trauma fracture in men and women. JAMA 2007; 297: 387-94.
119. Ryg J, Rejnmark L, Overgaard S, Brixen K, Vestergaard P. Hip fracture patients at risk of second hip fracture: A nationwide population-based cohort study of 169,145 cases during 1977-2001. J Bone Miner Res 2009; 24: 1299-307.
120. van Geel TA, van Helden S, Geusens PP, Winkens B, Dinant GJ. Clinical subsequent fractures cluster in time after first fractures. Ann Rheum Dis 2009; 68: 99-102.
121. Geusens P. Strategies for treatment to prevent fragility fractures in postmenopausal women. Best Pract Res Clin Rheumatol 2009; 23: 727-40.
122. Adami S, Bertoldo F, Gatti D, Minisola G, Rossini M, Sinigaglia L, et al. Treatment thresholds for osteoporosis and reimbursability criteria: Perspectives associated with fracture risk-assessment tools. Calcif Tissue Int 2013; 93: 195-200.
123. Nayak S, Edwards DL, Saleh AA, Greenspan SL. Performance of risk assessment instruments for predicting osteoporotic fracture risk: a systematic review. Osteoporos Int 2014; 25: 23-49.
124. Adami S, Bianchi G, Brandi ML, Di Munno O, Frediani B, Gatti D, et al. Validation and further development of the WHO 10-year fracture risk assessment tool in Italian postmenopausal women: Project rationale and description. Clin Exp Rheumatol 2010; 28: 561-70.
125. Delmas PD. The role of markers of bone turnover in the assessment of fracture risk in postmenopausal women. Osteoporos Int 1998; 8(Suppl 1): S32-6.
126. Srivastava AK, Vliet EL, Lewiecki EM, Maricic M, Abdelmalek A, Gluck O, et al. Clinical use of serum and urine bone markers in the management of osteoporosis. Curr Med Res Opin 2005; 21: 1015-26.
127. Heaney RP. Is the paradigm shifting? Bone 2003; 33: 457-65.
128. Garnero P, Hausherr E, Chapuy MC, Marcelli C, Grandjean H, Muller C, et al. Markers of bone resorption predict hip fracture in elderly women: The EPIDOS Prospective Study. J Bone Miner Res1996; 11: 1531-8.
129. Garnero P, Sornay-Rendu E, Claustrat B, Delmas PD. Biochemical markers of bone turnover, endogenous hormones and the risk of fractures in postmenopausal women: The OFELY study. J Bone Miner Res 2000; 15: 1526-36.
130. Ross PD, Kress BC, Parson RE, Wasnich RD, Armour KA, Mizrahi IA. Serum bone alkaline phosphatase and calcaneus bone density predict fractures: a prospective study. Osteoporos Int 2000; 11: 76-82.
131. Hatch, R.P. Method for the synthesis of deoxypyridinoline. US5723619 (1998).
132. Delmas PD, Eastell R, Garnero P, Seibel MJ, Stepan J. The use of biochemical markers of bone turnover in osteoporosis. Osteoporos Int 2000; 11(Suppl 6): S2-S17.
133. Clemens, J.D., Eyre, D.R., Ochs, V.W. Synthetic peptide analogs of cross-linked n-telopeptides of type I collagen. WO1996036645 (1995), US5750647 (1998) & US5817755 (1998).
134. Eyre, D.R. Elisa kit for quantification of C-terminal telopeptides of type I collagen in human serum. US6204367 (2001).
135. Avnur, Z., Pedersen, S.S., Cerelli, M.J., Kempe, T.D. Assay for bone alkaline phosphatase. US6201109 (2001).
136. Kress BC, Mizrahi IA, Armour KW, Marcus R, Emkey RD, Santora AC. Use of bone alkaline phosphatase to monitor alendronate therapy in individual postmenopausal osteoporotic women. Clin Chem 1999; 45: 1009-17.
137. Hulmes DJ, Kadler KE, Mould AP, Hojima Y, Holmes DF, Cummings C, et al. Pleomorphism in type I collagen fibrils produced by persistence of the procollagen N-propeptide. J Mol Biol 1989; 210: 337-45.
138. Orum O, Hansen M, Jensen CH, Sørensen HA, Jensen LB, Hørslev-Petersen K, et al. Procollagen type I N-terminal propeptide (PINP) as an indicator of type I collagen metabolism: ELISA development, reference interval, and hypovitaminosis D induced hyperparathyroidism. Bone 1996; 19:157-63.
139. Jensen CH, Hansen M, Brandt J, Rasmussen HB, Jensen PB, Teisner B. Quantification of the N-terminal propeptide of human procollagen type I (PINP): comparison of ELISA and RIA with respect to different molecular forms. Clin Chim Acta 1998; 269: 31-41.
140. Gundberg CM, Nieman SD, Abrams S, Rosen H. Vitamin K status and bone health: An analysis of methods for determination of undercarboxylated osteocalcin. J Clin Endocrinol Metab 1998; 83: 3258-66.
141. Ferron M, Wei J, Yoshizawa T, Ducy P, Karsenty G. An ELISAbased method to quantify osteocalcin carboxylation in mice. Biochem Biophys Res Commun 2010; 397: 691-6.
142. Bonjour JP, Benoit V, Pourchaire O, Ferry M, Rousseau B, Souberbielle JC. Inhibition of markers of bone resorption by consumption of Vitamin D and calcium-fortified soft plain cheese by institutionalised elderly women. Br J Nutr 2009; 102: 962-6.
143. Bonjour JP, Benoit V, Rousseau B, Souberbielle JC. Consumption of Vitamin D and calcium-fortified soft white cheese lowers the biochemical marker of bone resorption TRAP 5b in postmenopausal women at moderate risk of osteoporosis fracture. J Nurt 2012; 142: 698-703.
144. Vasikaran S, Eastell R, Bruyère O, Foldes AJ, Garnero P, Griesmacher A, et al. Markers of bone turnover for the prediction of fracture risk and monitoring of osteoporosis treatment: A need for international reference standards. Osteoporos Int 2011; 22: 391-420.
145. Vasikaran S, Cooper C, Eastell R, Griesmacher A, Morris HA, Trenti T, et al. International Osteoporosis Foundation and International Federation of Clinical Chemistry and Laboratory Medicine position on bone marker standards in osteoporosis. Clin Chem Lab Med 2011; 49: 1271-4.
146. Matsumoto T, Ohnishi I, Bessho M, Imai K, Ohashi S, Nakamura K. Prediction of vertebral strength under loading conditions occurring in activities of daily living using a computed tomographybased nonlinear finite element method. Spine 2009; 34: 1464-9.
147. Bessho M, Ohnishi I, Matsumoto T, Imai K, Ohashi S, Nakamura K. Prediction of proximal femur strength using a CT-based nonlinear finite element method: differences in predicted fracture load and site with changing load and boundary conditions. Bone 2009; 45: 226-31.
148. Imai K, Ohnishi I, Yamamoto S, Nakamura K. In vivo assessment of lumbar vertebral strength in elderly women using computed tomography-based nonlinear finite element model. Spine 2008; 33: 27-32.
149. Garvan Medical Research Institute, O.B.B.P. Fracture Risk Calculator. Available at: http://garvan.org.au/promotions/bone-fracturerisk/ calculator/ (Accessed on: January 16, 2014).
150. van den Bergh JP, van Geel TA, Lems WF, Geusens PP. Assessment of individual fracture risk: FRAX and beyond. Curr Osteoporos Rep 2010; 8: 131-7.
151. Yamagishi S. Role of advanced glycation end products (AGEs) in osteoporosis in diabetes. Curr Drug Targets 2011; 12: 2096-102.
152. Shiraki M, Kuroda T, Tanaka S, Saito M, Fukunaga M, Nakamura T. Nonenzymatic collagen cross-links induced by glycoxidation (pentosidine) predicts vertebral fractures. J Bone Miner Metab 2008; 26: 93-100.